Making Genomics Work for Pharma

Making Genomics Work for Pharma

Written By
Stacy Lawrence
Stacy Lawrence
Jul 7, 2004
1 minute read
eWeek content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More

With the explosion of data-intensive research tools, pharmaceutical companies are still struggling to understand how to most effectively make use of them. This package has the first few of a series of interviews with pharmaceutical executives about how are beginning to use genomics to enhance their drug discovery pipelines. It examines the usefulness of microarrays, proteomics, genotyping, RNAi and other genomic tools. It includes interviews from top executives with Pfizer, GlaxoSmithKline, Astrazeneca, and Merck.

Read the full story at Bio-IT World

eWeek Logo

eWeek has the latest technology news and analysis, buying guides, and product reviews for IT professionals and technology buyers. The site's focus is on innovative solutions and covering in-depth technical content. eWeek stays on the cutting edge of technology news and IT trends through interviews and expert analysis. Gain insight from top innovators and thought leaders in the fields of IT, business, enterprise software, startups, and more.

Property of TechnologyAdvice. © 2026 TechnologyAdvice. All Rights Reserved

Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.